Free Trial

Promising Value Stocks To Watch Now - April 28th

SpringWorks Therapeutics logo with Medical background

SpringWorks Therapeutics, ProShares UltraPro Short QQQ, iShares Bitcoin Trust, Intel, and Berkshire Hathaway are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Value stocks within the last several days.

SpringWorks Therapeutics (SWTX)

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.

Shares of SWTX stock traded up $1.45 on Monday, reaching $46.17. 73,642,212 shares of the company's stock traded hands, compared to its average volume of 1,764,080. SpringWorks Therapeutics has a 12-month low of $28.21 and a 12-month high of $62.00. The business's 50 day moving average price is $46.20 and its two-hundred day moving average price is $40.64. The company has a market capitalization of $3.46 billion, a P/E ratio of -13.27 and a beta of 0.79.

Read Our Latest Research Report on SWTX

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

NASDAQ:SQQQ traded up $0.29 during mid-day trading on Monday, hitting $31.94. 88,030,781 shares of the company's stock traded hands, compared to its average volume of 49,796,575. ProShares UltraPro Short QQQ has a 12 month low of $26.21 and a 12 month high of $61.60. The firm has a 50 day moving average of $36.54 and a two-hundred day moving average of $33.17.

Read Our Latest Research Report on SQQQ

iShares Bitcoin Trust (IBIT)

The IShares Bitcoin Trust Registered (IBIT) is an exchange-traded fund that mostly invests in long btc, short usd currency. The fund is a passively managed fund that seeks to track the spot price of Bitcoin. IBIT was launched on Jan 5, 2024 and is issued by BlackRock.

Shares of IBIT traded down $0.71 on Monday, hitting $53.56. The company's stock had a trading volume of 29,132,623 shares, compared to its average volume of 45,928,105. The company has a 50 day moving average price of $48.79 and a 200 day moving average price of $50.80. iShares Bitcoin Trust has a fifty-two week low of $28.23 and a fifty-two week high of $61.75.

Read Our Latest Research Report on IBIT

Intel (INTC)

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.

NASDAQ INTC traded up $0.45 on Monday, reaching $20.50. The company had a trading volume of 69,635,471 shares, compared to its average volume of 79,423,066. Intel has a 52 week low of $17.67 and a 52 week high of $37.16. The stock's 50 day moving average is $21.92 and its 200-day moving average is $21.85. The stock has a market cap of $89.37 billion, a price-to-earnings ratio of -4.68 and a beta of 1.13. The company has a quick ratio of 0.98, a current ratio of 1.33 and a debt-to-equity ratio of 0.44.

Read Our Latest Research Report on INTC

Berkshire Hathaway (BRK.B)

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. The company provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. It also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydroelectric, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets.

BRK.B traded down $1.71 during trading hours on Monday, hitting $529.25. 2,588,896 shares of the company's stock were exchanged, compared to its average volume of 4,130,010. The stock's 50-day moving average is $512.90 and its two-hundred day moving average is $480.62. Berkshire Hathaway has a 1-year low of $396.35 and a 1-year high of $539.00. The stock has a market cap of $1.14 trillion, a price-to-earnings ratio of 10.69, a PEG ratio of 3.45 and a beta of 0.80.

Read Our Latest Research Report on BRK.B

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SpringWorks Therapeutics Right Now?

Before you consider SpringWorks Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SpringWorks Therapeutics wasn't on the list.

While SpringWorks Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines